Cypher inhibitors represent a distinctive class of chemical compounds that exert their influence on cellular processes through targeted interference with specific signaling pathways. These inhibitors are designed to modulate cellular communication, particularly within the context of signal transduction cascades. At the molecular level, cypher inhibitors often interact with key components of cellular signaling networks, disrupting the intricate choreography of molecular events that regulate various physiological processes. These compounds are engineered to interfere with the transmission of signals across cellular membranes, impacting downstream molecular events and influencing cellular responses.
Cypher Inhibitors alludes to the clandestine nature of their action, as they effectively cipher or encode the signaling language of cells. These inhibitors are characterized by their selectivity, aiming to precisely block or attenuate specific pathways while minimizing off-target effects. Their development is grounded in a deep understanding of cellular signaling pathways, allowing for the creation of molecules that can selectively disrupt or modulate key nodes within these intricate networks. The structural design of cypher inhibitors often involves careful consideration of the three-dimensional arrangement of atoms, enabling them to fit snugly into the active sites of their target molecules. This precision in molecular design underlies their efficacy and specificity, making cypher inhibitors a promising class of compounds for further exploration in the realm of molecular biology and cellular regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A can disrupt actin polymerization, which indirectly affects Cypher's function due to its interaction with actin filaments. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
This compound can inhibit actin filament elongation, indirectly impacting Cypher's role in maintaining actin stability. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide can stabilize actin filaments, potentially altering Cypher's role in cardiac muscle contraction. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Phalloidin can bind to actin filaments and stabilize them, which can indirectly influence Cypher. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that can indirectly affect the actin cytoskeleton and thus influence Cypher's function. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
This myosin II inhibitor can affect the actin-myosin interaction, thus indirectly affecting Cypher's role. | ||||||
ML-9 | 105637-50-1 | sc-200519 sc-200519A sc-200519B sc-200519C | 10 mg 50 mg 100 mg 250 mg | $112.00 $449.00 $673.00 $1224.00 | 2 | |
ML-7 is a myosin light chain kinase inhibitor that could indirectly affect Cypher by altering actin-myosin dynamics. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor can indirectly influence Cypher's function through its impact on signaling pathways that control actin dynamics. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As an inhibitor of MEK, PD 98059 can indirectly impact Cypher through its influence on signaling pathways related to actin dynamics. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
This calcium chelator can influence calcium signaling, which can indirectly affect Cypher's role in cardiac muscle contraction. | ||||||